Alexander Saji, Ramadan Dina, Alkhayyat Haya, Al-Sharkawi Ibrahim, Backer K C Aboo, El-Sabban Fatma, Hussain Khalid
London Centre for Pediatric Endocrinology and Metabolism, Great Ormond Street, Hospital for Children NHS Trust, London, United kingdom.
Am J Med Genet A. 2005 Dec 15;139(3):227-30. doi: 10.1002/ajmg.a.31011.
Costello syndrome is characterized by mental retardation, loose skin, coarse facies, skeletal abnormalities, cardiovascular abnormalities (congenital heart defects, cardiomyopathy, rhythm disturbances), and predisposition to neoplasia. Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described. Hypoglycemia has been documented due to growth hormone and cortisol deficiency. We report on two patients with Costello syndrome and persistent hyperinsulinemic hypoglycemia and review the endocrine manifestations of Costello syndrome. Both patients required diazoxide therapy to stop the unregulated insulin secretion and maintain normoglycemia. The mechanism of persistent hyperinsulinism in patients with Costello syndrome is unclear.
科斯特洛综合征的特征包括智力发育迟缓、皮肤松弛、面容粗糙、骨骼异常、心血管异常(先天性心脏缺陷、心肌病、心律失常)以及易患肿瘤。已描述了内分泌异常,包括生长激素缺乏、肾上腺功能不全、葡萄糖耐量异常、伴有高催乳素血症和低血糖的甲状旁腺腺瘤。已证实低血糖是由生长激素和皮质醇缺乏所致。我们报告了两名患有科斯特洛综合征且持续性高胰岛素血症性低血糖的患者,并回顾了科斯特洛综合征的内分泌表现。两名患者均需要二氮嗪治疗以停止不受控制的胰岛素分泌并维持血糖正常。科斯特洛综合征患者持续性高胰岛素血症的机制尚不清楚。